A pooled analysis of injection site-related adverse events in patients with schizophrenia treated with olanzapine long-acting injection

Peer Review reports

Original Submission
29 Mar 2013	Submitted	Original manuscript
25 Jun 2013	Reviewed	Reviewer Report - Jacob Ballon
7 Jul 2013	Reviewed	Reviewer Report - Joshua Kantrowitz
30 Sep 2013	Author responded	Author comments - Susan Atkins
Resubmission - Version 2
30 Sep 2013	Submitted	Manuscript version 2
29 Nov 2013	Reviewed	Reviewer Report - Joshua Kantrowitz
2 Dec 2013	Reviewed	Reviewer Report - Jacob Ballon
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
9 Jan 2014	Editorially accepted
14 Jan 2014	Article published	10.1186/1471-244X-14-7

Back to article page